Regulatory and clinical considerations for biosimilar oncology drugs

Biological oncology products are integral to cancer treatment, but their high costs pose challenges to patients, families, providers, and insurers. The introduction of biosimilar agents—molecules that are similar in structure, function, activity, immunogenicity, and safety to the original biological...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Lancet Oncol
Main Authors: Bennett, Charles L, Chen, Brian, Hermanson, Terhi, Wyatt, Michael D, Schulz, Richard M, Georgantopoulos, Peter, Kessler, Samuel, Raisch, Dennis W, Qureshi, Zaina P, Lu, Z Kevin, Love, Bryan L, Noxon, Virginia, Bobolts, Laura, Armitage, Melissa, Bian, John, Ray, Paul, Ablin, Richard J, Hrushesky, William J, Macdougall, Iain C, Sartor, Oliver, Armitage, James O
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404762/
https://ncbi.nlm.nih.gov/pubmed/25456378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70365-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker